Loading...
Theratechnologies Inc.
THTX•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$3.17
$0.02(0.63%)
Theratechnologies Inc. (THTX) Financial Performance & Income Statement Overview
Review Theratechnologies Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
5.02%
↑ 5.02%
Operating Income Growth
176.92%
↑ 176.92%
Net Income Growth
65.33%
↑ 65.33%
Operating Cash Flow Growth
141.90%
↑ 141.90%
Operating Margin
8.44%
↑ 8.44%
Gross Margin
77.72%
↑ 77.72%
Net Profit Margin
-10.85%
↓ 10.85%
ROE
37.63%
↑ 37.63%
ROIC
58.86%
↑ 58.86%
Theratechnologies Inc. (THTX) Income Statement & Financial Overview
Review Theratechnologies Inc.'s (THTX) income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $19.05M | $25.002M | $22.60M | $22.02M |
| Cost of Revenue | $3.48M | $6.10M | $4.52M | $4.55M |
| Gross Profit | $15.56M | $18.91M | $18.08M | $17.47M |
| Gross Profit Ratio | $0.82 | $0.76 | $0.80 | $0.79 |
| R&D Expenses | $2.97M | $5.88M | $2.61M | $4.72M |
| SG&A Expenses | $10.70M | $12.10M | $9.25M | $9.46M |
| Operating Expenses | $13.67M | $17.99M | $11.87M | $14.18M |
| Total Costs & Expenses | $17.15M | $24.08M | $16.39M | $18.73M |
| Interest Income | $9000.00 | $355000.00 | $364000.00 | $342000.00 |
| Interest Expense | $1.13M | $2.42M | $2.66M | $2.69M |
| Depreciation & Amortization | $491000.00 | $493000.00 | $405000.00 | $1.26M |
| EBITDA | $2.04M | -$3.97M | $6.62M | $4.47M |
| EBITDA Ratio | $0.11 | -$0.16 | $0.29 | $0.20 |
| Operating Income | $1.90M | $919000.00 | $6.21M | $3.29M |
| Operating Income Ratio | $0.10 | $0.04 | $0.27 | $0.15 |
| Other Income/Expenses (Net) | -$1.47M | -$7.80M | -$2.37M | -$2.18M |
| Income Before Tax | $424000.00 | -$6.88M | $3.85M | $1.10M |
| Income Before Tax Ratio | $0.02 | -$0.28 | $0.17 | $0.05 |
| Income Tax Expense | $307000.00 | $1.02M | $756000.00 | $118000.00 |
| Net Income | $117000.00 | -$7.90M | $3.09M | $987000.00 |
| Net Income Ratio | $0.006 | -$0.32 | $0.14 | $0.04 |
| EPS | $0.002 | -$0.15 | $0.06 | $0.02 |
| Diluted EPS | $0.002 | -$0.16 | $0.06 | $0.02 |
| Weighted Avg Shares Outstanding | $49.36M | $51.52M | $51.52M | $49.36M |
| Weighted Avg Shares Outstanding (Diluted) | $50.40M | $49.37M | $49.37M | $49.37M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan